"Now the regulatory requirements for the industry are getting stricter and stricter. The implementation of two-vote system and one-vote system has changed the structure of drug circulation. There are many new models that need some resources and new solutions to land. I think the future is good for both the market and Shunfeng. Opportunity. " On April 27th, Ma Jiancong, Assistant to the President of SF Express Co., Ltd. and Director of Cold Transportation Division, said in an exclusive interview with Time Weekly reporter.
At present, it is reported that SF entered the pharmaceutical logistics industry on 20 14. This year, SF Holdings' revenue exceeded 38 billion yuan, and Wang Wei set up the Pharmaceutical Logistics Division alone. However, the outside world knows little about this, and SF Pharmaceutical Logistics is unknown in the industry.
Due to the lack of specialized cold chain logistics enterprises for refrigerated drugs in China, the number of specialized refrigerated transport vehicles is seriously insufficient, and the refrigeration technology of existing refrigerated transport vehicles lacks standardization, which highlights the contradiction between the high transportation requirements of pharmaceutical products and the current situation of cold chain logistics. Pharmaceutical cold chain logistics enterprises urgently need high-standard and standardized cold chain equipment investment.
Ma Jiancong believes that SF, as a leading express delivery enterprise, is "consistent" with the current national regulatory requirements for pharmaceutical logistics and transportation. "The transportation conditions of the pharmaceutical industry require that the types of customers it serves include downstream hospitals and CDC. They are all in the middle and high end of the logistics industry, which are basically consistent with SF's resources, management system and quality requirements. "